No Data
No Data
Biodexa Pharmaceuticals PLC to Present at the Emerging Growth Conference on February 19, 2025
Biodexa Pharmaceuticals Shares Are Trading Higher After the Company Received Fast Track Status From the FDA for ERap.
Biodexa Wins FDA Fast Track for ERapa, Targets Familial Adenomatous Polyposis Treatment
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
ADRs Close Higher; Youdao Inc. Climbs 42%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Can’t Trade 4Shit : My friend, you are not alone